These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36752485)

  • 1. Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure.
    Zile MR; Kahwash R; Sarkar S; Koehler J; Butler J
    JACC Heart Fail; 2023 Feb; 11(2):143-156. PubMed ID: 36752485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Arai S; Kawamura M; Gokan T; Yoshikawa K; Ogawa K; Ochi A; Munetsugu Y; Ito H; Shinke T
    Clin Cardiol; 2020 Dec; 43(12):1517-1523. PubMed ID: 32989791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
    Botto GL; Boriani G; Favale S; Landolina M; Molon G; Tondo C; Biffi M; Grandinetti G; De Filippo P; Raciti G; Padeletti L
    Trials; 2011 Feb; 12():44. PubMed ID: 21324118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy.
    Varma N; Auricchio A; Connolly AT; Boehmer J; Bahu M; Costanzo MR; Leonelli F; Yoo D; Singh J; Nabutovsky Y; Gold M
    Europace; 2021 Oct; 23(10):1586-1595. PubMed ID: 34198334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.
    Sharma V; Rathman LD; Small RS; Whellan DJ; Koehler J; Warman E; Abraham WT
    Heart Lung; 2015; 44(2):129-36. PubMed ID: 25543319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status.
    Capucci A; Wong JA; Gold MR; Boehmer J; Ahmed R; Kwan B; Thakur PH; Zhang Y; Jones PW; Healey JS
    JACC Clin Electrophysiol; 2022 Feb; 8(2):182-193. PubMed ID: 35210075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting.
    Cowie MR; Sarkar S; Koehler J; Whellan DJ; Crossley GH; Tang WH; Abraham WT; Sharma V; Santini M
    Eur Heart J; 2013 Aug; 34(31):2472-80. PubMed ID: 23513212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pulmonary artery pressure-guided therapy on heart failure readmission in a nationally representative cohort.
    Kishino Y; Kuno T; Malik AH; Lanier GM; Sims DB; Ruiz Duque E; Briasoulis A
    ESC Heart Fail; 2022 Aug; 9(4):2511-2517. PubMed ID: 35560987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
    Martens P; Deferm S; Bertrand PB; Verbrugge FH; Ramaekers J; Verhaert D; Dupont M; Vandervoort PM; Mullens W
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):895-906. PubMed ID: 31326478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
    Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
    JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of the association between ischemic etiology and the likelihood of heart failure hospitalization following cardiac resynchronization therapy.
    Powell AC; Rogstad TL; Deshmukh UU; Price SE; Simmons JD
    Clin Cardiol; 2017 Nov; 40(11):1090-1094. PubMed ID: 28846805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Botto GL; Padeletti L; Covino G; Pieragnoli P; Liccardo M; Mariconti B; Favale S; Molon G; De Filippo P; Bolognese L; Landolina M; Raciti G; Boriani G
    Int J Cardiol; 2017 Jun; 236():181-186. PubMed ID: 28131706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.